Tuico, Nestor O.

HRN: 18-22-29  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/23/2022
07/30/2022
IV
300mg
Q6
Sepsis; Decubitus Ulcer
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Dose  Wrong Dose

Overall appropriateness: No  Wrong Dose

Intervention



Type of Intervention done:

                    

           


Acceptance: